Natural history of intestinal neoplasms induced in rats by a single injection of methyl(acetoxymethyl)nitrosamine.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J M Rice.
Explore the source record for details and available documents.
Cryptococcosis was diagnosed in an adult male patas monkey (Erythrocebus patas) 9 months after importation. The disease was characterized by an open lesion on the buttock and epileptiform seizures. Diagnosis was confirmed through immunologic identification of the organism in serum and cerebrospinal fluid and by mycologic procedures performed on the cultured organism. The monkey was killed and cryptococcal organisms were found in the lung, brain, subcutaneous lesions, thyroid, pancreas, adrenals, and spinal cord. Retrospective analysis of stored serum indicated that the monkey was infected at the time of importation.
The Role of prenatal age, sex, and the maternal background upon the incidence, multiplicity, and spectrum of tumors induced by ethylnitrosourea has been studied in the offspring of reciprocal hybrids of the same genotype. The first generation (F1) offspring of C57BL/6J X C3HeB/FeJ and the reciprocal hybrids were observed throughout their life-span for tumor development following single i.p. injections of ethylnitrosourea (60 microng/g) given to pregnant mothers at 12, 14, 16, or 18 days of gestation. Animals exposed to ethylnitrosourea survived on the average for only 90 weeks. They developed by that age tumors in lungs, livers, ovaries, nervous system, and forestomach. Control mice killed at 90 weeks were essentially free of tumors. The fetal age at the time of administration of the carcinogen was one of the most significant modulators of tumor development in lung, liver, ovaries, and nervous system. The sex of the animals influenced the rate of development of liver tumors, whereas maternal background affected the multiplicity of lung tumors.
A transplacentally induced lung tumor of strain C3Hf mice grows progressively when transplanted to (C3Hf X A)F1 hybrid mice but not when transplanted to C3Hf recipients. Progressive tumor growth occurs in [(C3Hf X A)F1 X C3Hf] backcross mice inheriting the H-2a haplotype from the F1 parent. Furthermore, radioresistant immunity to the lung tumor can be induced in C3Hf mice by immunization with normal tissue of B10.A and B10.A(2R) but not of B10 or B10.A(5R) strain mice.
Intrauterine and early postnatal life are periods of exceptionally high susceptibility to certain kinds of chemical carcinogens. The most potent known transplacental carcinogens are direct acting alkylating agents. Most nonreactive compounds, which require enzymes for metabolic conversion into chemically reactive "proximate carcinogens," are less effective because the required enzymes are present at low levels in the fetus, and many proximate carcinogens are too reactive to reach the fetus when formed in maternal tissues. Despite this, many carcinogens which require metabolic activation are very active transplancentally, as the intrinsic susceptibility of rapidly dividing fetal cells compensates effectively for comparatively low tissue levels of reactive metabolites. Transplacental carcinogens of all kinds are most effective late in gestation, generally after organogenesis has begun and after the period of greatest susceptibility to teratogens. Only a small number of known carcinogens have been tested for transplacental carcinogenic activity. The great majority of tumors induced transplacentally in the well-studied rodent and lagomorph species (mouse, rat, Syrian hamster, and rabbit) have morphologic features of adult, rather than embryonal, tissues. A given agent tends to induce in a given species largely the same types of tumor when given transplacentally as when administered directly to postweaning animals, unless its carcinogenic effect in the latter is ascribable to some peculiarity of distribution, metabolism, or physiology. In a second species, the spectrum of tumors induced either before of after birth may be quite different. For bioassay of suspected carcinogens, the significance of perinatal carcinogenesis lies in the facts that the fetal and preweaning rodent is an extremely sensitive indicator of carcinogenic activity, and that the facile adaptibility of fetal cells to tissue culture and their rapid expression in vitro of properties of neoplastic transformation make possible a rapid in vivo/in vitro screening system for chemical carcinogens.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The immune response of mice to a transplacentally induced lung tumor was investigated with the microcytotoxicity (MC) assay. The tumor, originally induced in C3Hf mice, does not grow readily when transplanted to normal syngeneic C3Hf recipients. It grows readily, however, in (A C3Hf)F1 hybrids and in strain C3H mice, which express in their normal lung tissue a component which constitutes a strong lung tumor-associated transplantation antigen (TATA) in C3Hf mice. Both lung tumor-immunized C3Hf and tumor-bearing (A X C3Hf)F1 and C3H mice possessed lymphoid cells reactive against cultured lung tumor cells in the MC assay. Reactivity was also observed against cells cultured from normal lungs of (A X C3Hf)F1 and C3H mice, but not against cells similarly cultured from C3Hf of C57BL/6 mice. Anti-tumor MC was inhibited by serum-blocking factors present in some but not all tumor-bearing and tumor-immunized mice. The MC assay and detection by it of serum-blocking factors does not distinguish the effective anti-C3Hf lung tumor immune response of immunized C3Hf mice from the ineffective immune response of tumor-bearing (A X C3Hf)F1 and C3H mice. Furthermore, in lung tumor-bearing mice cells reactive in the MC assay may be directed against a normal tissue antigen rather than a tumor-associated antigen.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.